Development of octreotide-conjugated polymeric prodrug of bufalin for targeted delivery to somatostatin receptor 2 overexpressing breast cancer in vitro and in vivo
Tao Liu,1,* Tingting Jia,2,* Xia Yuan,2 Cheng Liu,1 Jian Sun,1 Zhenhua Ni,1 Jian Xu,1 Xuhui Wang,2 Yi Yuan2 1Centralab, 2Department of Pharmacy, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China *These authors contributed equally to...
Main Authors: | Liu T, Jia T, Yuan X, Liu C, Sun J, Ni Z, Xu J, Wang X, Yuan Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-05-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/development-of-octreotide-conjugated-polymeric-prodrug-of-bufalin-for--peer-reviewed-article-IJN |
Similar Items
-
Enhanced Intestinal Permeability of Bufalin by a Novel Bufalin-Peptide-Dendrimer Inclusion through Caco-2 Cell Monolayer
by: Chi-on Chan, et al.
Published: (2017-11-01) -
Bufalin-loaded vitamin E succinate-grafted-chitosan oligosaccharide/RGD conjugated TPGS mixed micelles demonstrated improved antitumor activity against drug-resistant colon cancer
by: Yuan Z, et al.
Published: (2018-11-01) -
Improved Antitumor Efficacy and Pharmacokinetics of Bufalin via PEGylated Liposomes
by: Jiani Yuan, et al.
Published: (2017-11-01) -
Global trends in bufalin application research for cancer from 2003 to 2022: A bibliometric and visualised analysis
by: Donghao Tang, et al.
Published: (2024-01-01) -
Influence of Different Ratios of DSPE-PEG2k on Ester Prodrug Self-Assembly Nanoparticles for Cell Migration and Proliferation Suppression
by: Zhang H, et al.
Published: (2024-03-01)